Brian Abrahams
Stock Analyst at RBC Capital
(2.02)
# 2,991
Out of 4,915 analysts
461
Total ratings
40.08%
Success rate
-9.79%
Average return
Main Sectors:
Stocks Rated by Brian Abrahams
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INCY Incyte | Maintains: Sector Perform | $68 → $72 | $76.35 | -5.70% | 22 | Jul 30, 2025 | |
| SRPT Sarepta Therapeutics | Maintains: Sector Perform | $25 → $23 | $16.98 | +35.45% | 35 | Jul 17, 2025 | |
| BCRX BioCryst Pharmaceuticals | Reiterates: Outperform | $13 | $8.14 | +59.71% | 19 | Jun 30, 2025 | |
| BIIB Biogen | Reiterates: Outperform | $213 | $130.00 | +63.85% | 38 | Jun 27, 2025 | |
| CDTX Cidara Therapeutics | Maintains: Outperform | $35 → $75 | $62.30 | +20.39% | 1 | Jun 24, 2025 | |
| ACAD ACADIA Pharmaceuticals | Maintains: Outperform | $26 → $38 | $23.87 | +59.20% | 1 | Jun 23, 2025 | |
| VRTX Vertex Pharmaceuticals | Maintains: Sector Perform | $423 → $420 | $466.90 | -10.04% | 53 | Jun 17, 2025 | |
| MLTX MoonLake Immunotherapeutics | Reiterates: Outperform | $67 | $51.39 | +30.39% | 2 | Jun 3, 2025 | |
| NBIX Neurocrine Biosciences | Reiterates: Outperform | $145 | $131.35 | +10.39% | 20 | Jun 2, 2025 | |
| REGN Regeneron Pharmaceuticals | Reiterates: Outperform | $943 | $553.15 | +70.48% | 32 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $31 | $6.12 | +406.54% | 5 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $21 → $20 | $12.52 | +59.74% | 3 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sector Perform | $1.5 | $0.44 | +239.14% | 6 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $34 → $33 | $3.95 | +735.44% | 12 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $58 → $55 | $30.98 | +77.53% | 14 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $57 → $58 | $52.17 | +11.18% | 20 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $65 → $58 | $9.35 | +520.32% | 8 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $84 | $39.53 | +112.50% | 1 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $31 | $14.48 | +114.09% | 1 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $4 → $3 | $1.54 | +94.81% | 13 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sector Perform | $4 | $2.05 | +95.12% | 6 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $24 → $20 | $7.03 | +184.50% | 10 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $84 → $90 | $115.07 | -21.79% | 31 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $139 → $143 | $102.59 | +39.39% | 2 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $40 | $22.41 | +78.49% | 1 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Perform | $20 → $1.5 | $1.27 | +18.11% | 15 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Perform | $48 → $2 | $0.89 | +124.59% | 11 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Sector Perform | $4 | $8.69 | -53.94% | 21 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $32 → $30 | $33.12 | -9.41% | 11 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $13 → $12 | $9.57 | +25.39% | 14 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $22 | $9.30 | +136.56% | 9 | Jun 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $25 → $15 | $7.55 | +98.68% | 14 | Oct 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $12 → $9 | $4.09 | +120.32% | 3 | Mar 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $21 → $33 | $67.02 | -50.76% | 3 | Nov 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $27.34 | - | 4 | Dec 4, 2017 |
Incyte
Jul 30, 2025
Maintains: Sector Perform
Price Target: $68 → $72
Current: $76.35
Upside: -5.70%
Sarepta Therapeutics
Jul 17, 2025
Maintains: Sector Perform
Price Target: $25 → $23
Current: $16.98
Upside: +35.45%
BioCryst Pharmaceuticals
Jun 30, 2025
Reiterates: Outperform
Price Target: $13
Current: $8.14
Upside: +59.71%
Biogen
Jun 27, 2025
Reiterates: Outperform
Price Target: $213
Current: $130.00
Upside: +63.85%
Cidara Therapeutics
Jun 24, 2025
Maintains: Outperform
Price Target: $35 → $75
Current: $62.30
Upside: +20.39%
ACADIA Pharmaceuticals
Jun 23, 2025
Maintains: Outperform
Price Target: $26 → $38
Current: $23.87
Upside: +59.20%
Vertex Pharmaceuticals
Jun 17, 2025
Maintains: Sector Perform
Price Target: $423 → $420
Current: $466.90
Upside: -10.04%
MoonLake Immunotherapeutics
Jun 3, 2025
Reiterates: Outperform
Price Target: $67
Current: $51.39
Upside: +30.39%
Neurocrine Biosciences
Jun 2, 2025
Reiterates: Outperform
Price Target: $145
Current: $131.35
Upside: +10.39%
Regeneron Pharmaceuticals
May 27, 2025
Reiterates: Outperform
Price Target: $943
Current: $553.15
Upside: +70.48%
May 15, 2025
Reiterates: Outperform
Price Target: $31
Current: $6.12
Upside: +406.54%
May 15, 2025
Maintains: Outperform
Price Target: $21 → $20
Current: $12.52
Upside: +59.74%
May 14, 2025
Reiterates: Sector Perform
Price Target: $1.5
Current: $0.44
Upside: +239.14%
May 13, 2025
Maintains: Outperform
Price Target: $34 → $33
Current: $3.95
Upside: +735.44%
May 13, 2025
Maintains: Outperform
Price Target: $58 → $55
Current: $30.98
Upside: +77.53%
May 7, 2025
Maintains: Outperform
Price Target: $57 → $58
Current: $52.17
Upside: +11.18%
May 7, 2025
Maintains: Outperform
Price Target: $65 → $58
Current: $9.35
Upside: +520.32%
Apr 22, 2025
Reiterates: Outperform
Price Target: $84
Current: $39.53
Upside: +112.50%
Mar 7, 2025
Initiates: Outperform
Price Target: $31
Current: $14.48
Upside: +114.09%
Mar 4, 2025
Maintains: Sector Perform
Price Target: $4 → $3
Current: $1.54
Upside: +94.81%
Mar 4, 2025
Reiterates: Sector Perform
Price Target: $4
Current: $2.05
Upside: +95.12%
Feb 21, 2025
Maintains: Sector Perform
Price Target: $24 → $20
Current: $7.03
Upside: +184.50%
Feb 12, 2025
Maintains: Sector Perform
Price Target: $84 → $90
Current: $115.07
Upside: -21.79%
Feb 3, 2025
Maintains: Outperform
Price Target: $139 → $143
Current: $102.59
Upside: +39.39%
Jan 28, 2025
Reiterates: Outperform
Price Target: $40
Current: $22.41
Upside: +78.49%
Jan 10, 2025
Downgrades: Sector Perform
Price Target: $20 → $1.5
Current: $1.27
Upside: +18.11%
Dec 20, 2024
Downgrades: Sector Perform
Price Target: $48 → $2
Current: $0.89
Upside: +124.59%
Nov 21, 2024
Upgrades: Sector Perform
Price Target: $4
Current: $8.69
Upside: -53.94%
Nov 1, 2024
Maintains: Sector Perform
Price Target: $32 → $30
Current: $33.12
Upside: -9.41%
Aug 6, 2024
Maintains: Sector Perform
Price Target: $13 → $12
Current: $9.57
Upside: +25.39%
Jun 5, 2024
Reiterates: Outperform
Price Target: $22
Current: $9.30
Upside: +136.56%
Oct 2, 2023
Maintains: Sector Perform
Price Target: $25 → $15
Current: $7.55
Upside: +98.68%
Mar 31, 2022
Maintains: Sector Perform
Price Target: $12 → $9
Current: $4.09
Upside: +120.32%
Nov 3, 2021
Maintains: Sector Perform
Price Target: $21 → $33
Current: $67.02
Upside: -50.76%
Dec 4, 2017
Upgrades: Buy
Price Target: n/a
Current: $27.34
Upside: -